Cabaletta Bio Highlights Pivotal Myositis Trial, No-Preconditioning CAR-T Push at TD Cowen Conference

Cabaletta Bio (NASDAQ:CABA) used a fireside chat at TD Cowen’s 46th Annual Health Care Conference to highlight progress ...
Healio

CD19 CAR-T therapy yields long-term benefits in lupus, myositis, systemic sclerosis

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — CD19 chimeric antigen receptor T-cell therapy led to remission, or ceased disease progression, over ...
Seeking Alpha

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress

– 7 of 8 myositis patients achieved clinically meaningful TIS responses after discontinuation of all immunomodulators, while off or actively tapering steroids; responses were sustained throughout the ...
Healio

Detailed physical exam, medical history key to 'ruling out' dermatomyositis from lupus

Please provide your email address to receive an email when new articles are posted on . A thorough physical exam and attention to a patient’s medical history are integral to differentiating ...
Hartford Courant

There are more than 100 autoimmune diseases, and they mostly strike women. Here’s what to know

Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. What are called autoimmune diseases can ...